Obermatt

Suzuken

TYO:9987 · JP3398000004
Health Care Providers & ServicesLarge

360

60
Medium confidence — indicative
EV / EBIT97
Price / Owner Earnings67
Owner Earnings Yield99
Dividend Yield47
Price/Sales95
EV / Gross Profit98
Price/Book75
Return on Capital67
Cash Return on Capital65
Return on Equity59
EBIT Margin19
Gross Profitability39
Cash Conversion7
Accruals48
Owner Earnings Margin44
Sales growth26
Profit Growth65
Long-Term EPS Growth12
Reinvestment77
Price momentum55
Debt load98
Refinancing51
Debt Payback100
Liquidity98
Analyst ratings37
Opinion Changes50
Price Target Upside65
Market mood39
Value Creation7/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Suzuken clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeTSE
Founded1946
Employees10
ISINJP3398000004
Last UpdateApr 2, 2026
Index & Theme
Health DiagnosticsPharmacovigilanceHealth CareManufacturingPharmaceutical

Description

Analysis

Bargain bin

Suzuken Co., Ltd. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is attractive. The owner-earnings multiple stands at 9.0×; owner earnings: the cash an owner could take out each year.

Growth is tepid; the safety picture is uncertain. The company scores 7/20 on our value-creation score: creating some value.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
90
2023202420252026

All-time high

98

Jan 2024

All-time low

51

Jan 2025

Average rank

79

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
95
95
97
93
Price/Earnings
82
64
56
50
Price/Book
75
83
79
95
Dividend Yield
47
41
40
51
Value (overall)
84
77
73
75

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Suzuken with its peers
H.U. Group Holdings
TYO:4544
83
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Toho Holdings
TYO:8129
46
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
JW
KSC:096760
97
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
MediPal Holdings
TYO:7459
52
CountryJapan
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Daewon Pharmaceutical
KSC:003220
46
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Sigma Healthcare
ASX:SIG
60
CountryAustralia
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →